French international pioneer in respiratory health.

Based in Nice, this excellence center aims to develop innovative approaches for diagnosing, treating and preventing respiratory diseases.

Our Upcoming Events

Events

AI in the Next World of Thoracic Pathology

10/06/2026

- 10/07/2026

In Nice, an international congress will explore the role of artificial intelligence in making thoracic pathology diagnosis faster, more precise and more personalized.

Events

Mois Sans Tabac 2026: RespirERA Institute Organises a Respiratory Health Event in Nice

11/04/2026

On 4 November 2026, IHU RespirERA will hold a free public event in Nice focusing on smoking prevention, respiratory health and screening.

Our News

Publication

Pulmonary fibrosis: the FGFR3 decoy receptor, a promising avenue

Tested in human cells and mice, the sFGFR3-Fc decoy receptor reduced several mechanisms associated with idiopathic pulmonary fibrosis.

Publication

Liquid biopsy and lung cancer: what are the challenges of bringing testing closer to patients?

Professors Paul Hofman and Umberto Malapelle analyze the conditions necessary to bring liquid biopsies closer to healthcare facilities without compromising their reliability.

Featured

Professor Paul Hofman, appointed Guest Editor of a Special Topic on liquid biopsy

Professor Paul Hofman, Director of RespirERA Institute, is the Guest Editor of a Special Topic on liquid biopsy and treatment resistance in lung cancer.

Our Strategic Priorities

IHU RespirERA structures its actions around four complementary strategic priorities. Together, they aim to improve the understanding and prevention of respiratory diseases, enhance their diagnosis, personalize patient care, and widely disseminate research-driven innovations for the benefit of patients and society.

Prevention and Early Diagnosis

Develop innovative approaches to prevention and early diagnosis to detect respiratory diseases as early as possible and improve patient care pathways.

Complex Data, Resources and AI

Leverage health data and artificial intelligence to better understand, predict, and personalize the management of respiratory diseases.

Environmental and Aging Impact

Analyze the impact of environmental exposures and biological aging to anticipate risks and strengthen the prevention of respiratory diseases.

Training and Dissemination

Educate, inform, and share innovations to sustainably advance the management of respiratory diseases.

Our Missions

IHU RespirERA is committed to five key missions to explore the impact of aging and the environment on respiratory health, placing the patient at the heart of its projects.

Understand

the mechanisms of respiratory diseases to better address them.

Prevent

by identifying environmental risk factors and developing effective prevention strategies.

Treat

by creating personalized treatments tailored to each patient’s specific needs.

Innovate

by integrating new technologies, including artificial intelligence and robotics, to enhance diagnosis and care.

Educate & Train

healthcare professionals and the general public on emerging technologies and best practices.

Our Strategy

IHU RespirERA is built on a synergy between researchers, clinicians, patient associations, and industry partners, fostering effective collaboration to understand and treat respiratory diseases. This holistic approach considers all aspects of these pathologies, from biological factors to environmental impacts, to develop comprehensive and innovative solutions. The Provence-Alpes-Côte d’Azur region, significantly affected by pollution and an aging population, serves as our "living laboratory", enabling us to develop real-world solutions tailored to environmental and health challenges.